#JPM22 - Deal­mak­ing in 2022: What's Big Phar­ma look­ing for and what is it will­ing to pay?

John Car­roll:

Okay, well, thanks every­body for com­ing out to­day. We had a ton of reg­is­tra­tions for this pan­el dis­cus­sion about deal­mak­ing in 2022. I think that every year is a big year when it comes to deal­mak­ing, M&A, and busi­ness de­vel­op­ment deals. And we’re cer­tain­ly see­ing a lot of in­ter­est this year, par­tic­u­lar­ly af­ter a very in­ter­est­ing 2021 — set the stage for a lot of peo­ple look­ing at where they’re at in terms of strat­e­gy, and how they po­si­tion their com­pa­ny go­ing in­to the new year.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER